The University of Greenwich, represented by Dennis Douroumis, participated to the MedFIT 2020 pitch sessions. They have been awarded in the “Collaborative and Licensing Opportunity” category !

“We have developed a 3D additive manufacturing process for printing polymeric bioresorbable drug eluting stents. The technology can be applied to patients suffering from coronary artery diseases and presents the following advantages:

• Fabricate personalized bioresorbable drug eluting stents
• Print novel stent designs with high performance and excellent mechanical properties
• Deliver more than one drug substances (e.g. antiproliferative, antiplatelet)
• Stents disappear 12 – 24 months after implantation
• Cost effective manufacturing”

Dennis Douroumis
Professor in Pharmaceutical Technology and Process Engineering
University of Greenwich